Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Real-life Efficacy and Safety of a Fixed-dose Telmisartan/Hydrochlorothiazide, Including Its Effect on Plasma Potassium and on Glucose and Lipid Metabolism Parameters in Patients With Essential Arterial Hypertension

NCT01392534 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01392534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01392534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Real-life Efficacy and Safety of a Fixed-dose Telmisartan/Hydrochlorothiazide, Including Its Effect on Plasma Potassium and on Glucose and Lipid Metabolism Parameters in Patients With Essential Arterial Hypertension
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
July 31, 2010
Completion date
December 31, 2010
Enrollment
1,586 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary hypertension